MedTrace Logo

Validity of Neurocognitive Assessment Methods in Childhood ADHD

NCT04201509 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2019-12-20

No results posted yet for this study

Summary

The aim of the study is to examine the prospective validity of neurocognitive functions and emotional factors in schoolchildren with ADHD and a control group of typically developing schoolchildren at baseline and after three years.

Conditions

  • Neurodevelopmental Disorders
  • Attention Deficit Hyperactivity Disorder

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Region Skane

    lead OTHER

Principal Investigators

  • Peik Gustafsson, Dr · Lund University

Eligibility

Min Age
7 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-01
Primary Completion
2016-01-01
Completion
2019-11-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04201509 on ClinicalTrials.gov